This page is part of the CH IDMP (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

Xospata

This chapter presents various products in the IDMP / FHIR format.

XOSPATA 40 mg 84 Stk

The following data example illustrates the composition of the product Xospata 40 mg

Description

Xospata wird angewendet für die Behandlung von erwachsenen Patienten, die an rezidivierter oder refraktärer akuter myeloider Leukämie (AML) mit FMS-ähnlichen Tyrosinkinase 3 (FLT3)-Mutationen leiden.

Fig. 5: PADCEV 30 mg

FHIR Examples

Representation of IDMP data attributes as FHIR XML and JSON: FHIR Example

IDMP Dataexample

Representation of IDMP/FHIR data elements:

Fig. 6: XOSPATA 40 mg